mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.058 |
0.3 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |